MediWound Ltd.
MDWD
$16.29
-$0.06-0.37%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | 9.40% | 6.08% | -54.05% | -17.70% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 9.40% | 6.08% | -54.05% | -17.70% | |
| Cost of Revenue | 6.88% | 26.95% | 33.50% | 15.17% | |
| Gross Profit | 25.59% | -60.69% | -91.19% | -63.19% | |
| SG&A Expenses | 43.27% | -2.79% | -5.71% | -5.40% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -91.96% | -- | -- | -- | |
| Total Operating Expenses | 26.45% | 8.74% | 5.92% | -13.45% | |
| Operating Income | -48.62% | -11.90% | -251.87% | 5.76% | |
| Income Before Tax | -139.68% | -779.63% | 78.04% | 48.78% | |
| Income Tax Expenses | -85.00% | -116.67% | 84.62% | 860.00% | |
| Earnings from Continuing Operations | -124.21% | -788.32% | 76.63% | 47.70% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -124.21% | -788.32% | 76.63% | 47.70% | |
| EBIT | -48.62% | -11.90% | -251.87% | 5.76% | |
| EBITDA | -50.40% | -11.78% | -235.83% | 6.48% | |
| EPS Basic | -91.64% | -782.91% | 83.95% | 72.87% | |
| Normalized Basic EPS | 67.23% | -774.29% | -8.68% | -- | |
| EPS Diluted | -91.64% | -782.91% | 83.95% | 72.87% | |
| Normalized Diluted EPS | 67.23% | -774.29% | -8.68% | -- | |
| Average Basic Shares Outstanding | 17.04% | 0.77% | 45.59% | 92.71% | |
| Average Diluted Shares Outstanding | 17.04% | 0.77% | 45.59% | 92.71% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |